TNSN08335A1 - ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME - Google Patents

ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME

Info

Publication number
TNSN08335A1
TNSN08335A1 TNP2008000335A TNSN08335A TNSN08335A1 TN SN08335 A1 TNSN08335 A1 TN SN08335A1 TN P2008000335 A TNP2008000335 A TN P2008000335A TN SN08335 A TNSN08335 A TN SN08335A TN SN08335 A1 TNSN08335 A1 TN SN08335A1
Authority
TN
Tunisia
Prior art keywords
inhibitor
association
atherothrombotics
conversion enzyme
angiotensin conversion
Prior art date
Application number
TNP2008000335A
Other languages
French (fr)
Inventor
Sansilvestri-Morel Patricia
Rupin Alain
Fratacci Marie-Dominique
Lerond Laurence
La Vielle Gilbert
Verbeuren Tony
Vallez Marie-Odile
Original Assignee
Les Laboratoires Serviers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Serviers filed Critical Les Laboratoires Serviers
Priority to TNP2008000335A priority Critical patent/TNSN08335A1/en
Publication of TNSN08335A1 publication Critical patent/TNSN08335A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ASSOCIATION ENTRE UN ANTI-ATHEROTHROMBOTIQUE ET UN INHIBITEUR DE L'ENZYME DE CONVERSION Association d'un anti-athérothrombotique et d'un inhibiteur de l'enzyme de conversion de l'angiotensine (IECA), ainsi que les compositions pharmaceutiques qui les contiennent.ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTIC AND INHIBITOR OF THE CONVERSION ENZYME Combination of an anti-atherothrombotic and an angiotensin converting enzyme (ACE) inhibitor, as well as pharmaceutical compositions containing them.

TNP2008000335A 2008-08-21 2008-08-21 ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME TNSN08335A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TNP2008000335A TNSN08335A1 (en) 2008-08-21 2008-08-21 ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TNP2008000335A TNSN08335A1 (en) 2008-08-21 2008-08-21 ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME

Publications (1)

Publication Number Publication Date
TNSN08335A1 true TNSN08335A1 (en) 2009-12-29

Family

ID=59799036

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2008000335A TNSN08335A1 (en) 2008-08-21 2008-08-21 ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME

Country Status (1)

Country Link
TN (1) TNSN08335A1 (en)

Similar Documents

Publication Publication Date Title
MA30497B1 (en) ANTIBODIES AND IMMUNO-CONJUGATES, AND THEIR USES.
MA30945B1 (en) ANTI-TAT226 AND IMMUNOCONJUGATED ANTIBODIES
MA33208B1 (en) ANTI-FGFR3 ANTIBODIES AND METHODS OF USE THEREOF
MX2009008430A (en) Anti-robo4 antibodies and uses therefor.
EP1904290A4 (en) Aluminum phosphate based microspheres
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
CY1110337T1 (en) PREGAMPALIN PREPARATION AND RELATED UNIONS
MA34881B1 (en) ANTIBODIES AND ANTI-MESOTHELIN IMMUNOCONJUGATES
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
MA30531B1 (en) ANTI-DLL4 ANTIBODIES AND METHODS OF USE
UA104005C2 (en) 2-oxo-1,2-dihydro-quinoline modulators of immune function
MA33198B1 (en) ANTI-HER DI-SPECIFIC ANTIBODIES
CO6210786A2 (en) IMPLEMENTATION OF ORAL CARE WHICH HAS AN ORAL CARE AGENT
MA33551B1 (en) ANTI-EGFL1 HUMANIZED ANTIBODIES AND METHODS OF USING SAME
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
CR10280A (en) EFGL7 ANTIBODIES AND METHODS OF USE
UY31273A1 (en) PHENILENDIAMINS REPLACED AS INHIBITORS OF INTERACTION BETWEEN MDM2 AND P53
AR058574A1 (en) ASSOCIATION OF AN INHIBITOR OF THE SINUSAL CURRENT I AND OF AN INHIBITOR OF THE CONVERSION ENZYME AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
WO2009102707A3 (en) Substituted oxazaphosphorines
HK1112928A1 (en) Cspcna isoform modifications and uses thereof
MA30374B1 (en) ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME
TNSN08335A1 (en) ASSOCIATION BETWEEN ANTI-ATHEROTHROMBOTICS AND AN INHIBITOR OF THE ANGIOTENSIN CONVERSION ENZYME
MA31132B1 (en) A combination of sinusoidal inhibitor and beta-blockers.
MY154024A (en) Oral care compositions and methods
MX2008013437A (en) Method for administering tolperisone.